Hyperviscosity syndrome in hematological diseases and therapeutic apheresis

International Journal of Artificial Organs

Volumn 28, Issue 10, 2005, Pages 1032-1038

  Accorsi, Patrizia ^a   Passeri, C ^a   Onofrillo, D ^a   Iacone, A ^a  

^a SPIRITO SANTO HOSPITAL   (Italy)

Author keywords

Hyperviscosity; Pleiocytosic; Sclerocytic and sieric syndrome; Therapeutic apheresis

Indexed keywords

BLOOD COMPONENT; CLASSIFIEDS; CLINICAL SIGNS; CLINICAL SYMPTOMS; DEFINITIVE THERAPY; HEMATOLOGICAL DISEASE; HYPERVISCOSITY; PLEIOCYTOSIC; SCLEROCYTIC AND SIERIC SYNDROME; THERAPEUTIC APHERESIS;

ALLOPURINOL; ALPHA INTERFERON; ANTIBIOTIC AGENT; OXYGEN; RIBAVIRIN;

AMYLOIDOSIS; APHERESIS; ARTICLE; BACTERIAL INFECTION; BLOOD COMPONENT; BLOOD RHEOLOGY; CRYOGLOBULINEMIA; DISEASE CLASSIFICATION; ERYTHROCYTE TRANSFUSION; HEMATOLOGIC DISEASE; HEPATITIS C; HUMAN; HYPERVISCOSITY SYNDROME; LEUKAPHERESIS; LEUKOCYTOSIS; LEUKOSTASIS; MALARIA; MEDICAL DECISION MAKING; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PLASMAPHERESIS; PLEOCYTOSIS; POLYCYTHEMIA VERA; SCLEROSIS; SICKLE CELL ANEMIA; SYMPTOMATOLOGY; TREATMENT PLANNING; WALDENSTROEM MACROGLOBULINEMIA;

EID: 29244473098     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880502801011     Document Type: Article

References (37)

1. Thurston GB. Viscoelasticity of human blood. Biophys J 1972; 12: 1205-17.
2. Undar A, Vaughan WK. Effects of mild hypothermic cardiopulmonary bypass on blood viscoelasticity in coronary artery bypass grafting patients. J Artif Organs 2002; 26: 964.
3. Melnikov AA, Vikulov AD, Bagrakova SV. Relationships between von Willebrand factor and hemorheology in sportsmen. Clin Hemorheol Microcirc 2003; 29: 19-24.
4. Chien S, Usami S, Dellenback RJ, Gregersen MI. Shear-dependent interaction of plasma proteins with erythrocytes in blood rheology. Am J Physiol 1970; 219: 143-53.
5. Rampling MW. Red cell aggregation and yield stress. In: Lowe GDO, ed. Clinical Blood Rheology. Boca Raton: CRC; 1988. p 45-64.
6. McKay CB, Meiselman HJ. Osmolality-mediated Fahraeus and Fahraeus-Lindqvist effects for human RBC suspensions. Am J Physiol 1988; 254: 238-49.
7. Lacan A, Stoltz JF. Blood hyperviscosity syndromes. Classification and physiopathological understanding. Therapeutic-deductions. Ann Med Interne (Paris) 1983; 134: 395-410.
8. Wells RE, Merrill EW. Influence of flow properties of blood upon viscosity-hematocrit relationship. J Clin Invest 1962; 41: 1591-8.
9. Spivak JL. Polycythemia vera: Myths, mechanisms, and management. Blood 2002; 100: 4272-90.
10. Kaboth U, Rumpf KW, Liersch T, Vehmeyer K, Krieter D, Kaboth W. Advantages of isovolemic large-volume erythrocytapheresis as a rapidly effective and long-lasting treatment modality for red blood cell depletion in patients with polycythemia vera. Ther Apher 1997; 1: 131-4.
11. Valdovinos Mahave MC, Salvador Osuna C, del Agua C, Lanau Arilla MP, Vicente Camara MP. Respiratory distress syndrome due to hyperleukocytic-leukemias. An Med Interna 1999; 16: 359-60.
12. Baer MR. Management of unusual presentations of acute leukemia. Hematol Oncol Clin North Am 1993; 7: 275-92.
13. Williams JW, Beutler E, Erslev AJ, Lichtman MA, eds. In: Hematology. 4th ed. New York: McGraw Hill; 1990. p 1085-123.
14. Litchmann MA. Rheology of leukocytes, leukocyte suspensions, and blood in leukemia. J Clin Invest 1973; 52: 350-8.
15. Porcu P, Farag S, Marcucci G, Cataland SR, Kennedy MS, Bissell M. Leukocytoreduction for acute leukemia. Ther Apher 2002; 6: 399-400.
16. Goenka P, Chait M, Hitti IF, et al. Acute leukostasis pulmonary distress syndrome. J Fam Pract 1992; 35: 445-9.
17. Campbell J, Mitchell CA. Acute leg ischemia as a manifestation of the hyperleukocytosis syndrome in acute myeloid leukaemia. Am J Hematol 1994; 46: 167.
18. Nelson SC, Bruggers CS, Kurtzberg J, et al. Management of leukemic hyperleukocytosis with hydration, urinary alkalinization, and allopurinol. Are cranial irradiation and invasive cytoreduction necessary? Am J Pediatr Hematol Oncol 1993; 15: 351-5.
19. Bookchin RM, Lew VL. Pathophysiology of sickle cell anemia. Hematol Oncol Clin North Am 1996; 10: 1241-53.
20. Parise LV, Telen MJ. Erythrocyte adhesion in sickle cell disease. Curr Hematol Rep 2003; 2: 102-8.
21. Richardson SG, Matthews KB, Stuart J, Geddes AM, Wilcox RM. Serial changes in coagulation and viscosity during sickle-cell crisis. Br J Haematol 1979; 41: 95-103.
22. Richardson SG, Breeze GR, Stuart J. Hyperfibrinogenaemia and hyperviscosity in sickle-cell crisis. J Clin Pathol 1976; 29: 890-3.
23. Miller LH, Good MF, Milon G. Malaria pathogenesis. Science 1994; 264: 187-8.
24. Ridde MS, Jackson JL, Sanders JW, et al. Exchange transfusion as an adjunct therapy in severe Plasmodium falciparum malaria. A meta-analysis. Clin Infect Dis 2002; 34: 1192-8.
25. Drew MJ. Plasmapheresis in the dysproteinemias. Ther Apher 2002; 6: 45-52.
26. Weinstein R, Mahmood M. Case records of Massachusetts General Hospital. Weekly clinicopathological exercises. Case 6-2002. A 54-year-old woman with left, then right, central-retinal-vein occlusion. N Engl J Med 2002; 346: 603-10.
27. Kwaan HC, Bongu A. The hyperviscosity syndromes. Semin Thromb Hemost 1999; 25: 199-208.
28. Geraci JM, Hansen RM, Kueck BD. Plasma cell leukemia and hyperviscosity syndrome. South Med J 1990; 83: 800-5.
29. Isselbacker H, Braumwald E, Wilson J, Martin J, Fauci A, Kasper D. In: Harrison's principles of internal medicine. 13th ed. New York: McGraw Hill; 1994. p 1618-25.
30. Mehta J, Singhal S. Hyperviscosity syndrome in plasma cell dyscrasias. Semin Thromb Hemost 2003; 29: 467-71.
31. Clark WF, Rock GA, Buskard N, Shumak KH, LeBlond P, Anderson D, Sutton DM. Therapeutic plasma exchange: An update from the Canadian Apheresis Group. Ann Intern Med 1999; 131: 453-62.
32. Avnstorp C, Nielsen H, Drachmann O, Hippe E. Plasmapheresis in hyperviscosity syndrome. Acta Med Scand 1985; 217: 133-7.
33. Barlogie B, Shaughnessy J, Tricot G, Jacobson J, Zangari M, Anaissie E, Walker R, Crowley J. Treatment of multiple myeloma. Blood 2004; 103: 20-32.
34. Moist L, Nesrallah G, Kortas C, Espirtu E, Ostbye T, Clark WF. Plasma exchange in rapidly progressive renal failure due to multiple myeloma. A retrospective case series. Am J Nephrol 1999; 19: 45-50.
35. Dominguez JE, Sha E. Apheresis in cryoglobulinemia complicating hepatitis C and in other renal diseases. Ther Apher Dial 2002; 6: 69-76.
36. Siami GA, Siami FS. Cryofiltration apheresis in the United States. Ther Apher 1998; 2: 228-35.
37. Hausfater P, Cacoub P, Assogba U, Lebon P, Piette JC. Plasma exchange and interferon-alpha pharmacokinetics in patients with hepatitis C virus-associated systemic vasculitis. Nephron 2002; 91: 627-30.